Kiniksa Pharmaceuticals
KNSA
#4667
Rank
$1.42 B
Marketcap
🇧🇲 Bermuda
Country
$20.08
Share price
3.61%
Change (1 day)
46.68%
Change (1 year)
Categories
Kiniksa Pharmaceuticals (KNSA) - Cash on Hand
Cash on Hand as of December 2023 : $0.20 B
According to Kiniksa Pharmaceuticals
's latest financial reports the company has $0.20 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Kiniksa Pharmaceuticals - Cash on Hand chart (from 2017 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.20 B | 8.27% |
| 2022-12-31 | $0.19 B | 4.61% |
| 2021-12-31 | $0.18 B | -43.68% |
| 2020-12-31 | $0.32 B | 38.61% |
| 2019-12-31 | $0.23 B | -24.06% |
| 2018-12-31 | $0.30 B | 574.58% |
| 2017-12-31 | $45.55 M | -18.61% |
| 2016-12-31 | $55.97 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 0.88% | 🇺🇸 USA |